...
首页> 外文期刊>Heart rhythm: the official journal of the Heart Rhythm Society >Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR
【24h】

Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR

机译:随机,双盲,安慰剂对照研究,评估单个口服剂量vanoxerine的安全性和功效vanoxerine与最近的发病心房颤动或颤动到正常窦性节律的血管节奏:恢复SR

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND Vanoxerine is an oral, 1,4-dialkylpiperazine derivative antiarrhythmic drug being evaluated for pharmacological cardioversion of atrial fibrillation (AF).
机译:背景技术vanoxerine是口服,1,4-二烷基哌嗪衍生物抗心律失常药物,用于对心房颤动(AF)的药理心脏病源评估。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号